Coenzyme Q10 (COQ) in Huntington's Disease (2CARE)
The purpose of this research study is to assess the effect of Coenzyme Q10 (CoQ) on slowing the worsening of HD symptoms. Researchers will also assess the safety and the acceptability of CoQ in long-term use. The 2CARE study is designed and conducted by a group of clinical investigators and scientists, called the Huntington Study Group (HSG), which seeks to develop new treatments for Huntington\'s disease (HD).
KeywordsHuntington\'s Disease, Huntington\'s Study Group , Coenzyme Q10, 2CARE Study
Principal InvestigatorRamon Rodriguez Cruz, Assistant Professor
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.